The Claim
In White adults, the PCSK9 R46L genetic variant is associated with a 15% reduction in LDL cholesterol levels and a 47% lower risk of coronary heart disease over a 15-year period, with a hazard ratio of 0.50, suggesting that even moderate lifelong lowering of LDL cholesterol due to this genetic variation is linked to substantial cardiovascular protection.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
White adults with a certain gene variant have lower bad cholesterol and are nearly half as likely to get heart disease over 15 years — showing that even a small, lifelong drop in cholesterol can really protect your heart.
See the scientific wording
In White adults, a specific PCSK9 R46L variant is associated with a 15 percent reduction in LDL cholesterol and a 47 percent lower risk of coronary heart disease over 15 years, with a hazard ratio of 0.50, indicating that even moderate lifelong LDL lowering due to genetic variation is linked to substantial cardiovascular protection.
What the research says
1 studyStudy: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
The study looked at a specific gene change in White adults and found it lowered bad cholesterol and cut heart disease risk by nearly half over 15 years — exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.